Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Lewy Body disease and suicidality after dopamine agonist withdrawal

  • Melissa J. Nirenberg, Associate Professor of Neurology, NYU School of Medicine, New York, NY, USAmelissa.nirenberg@nyumc.org
Submitted October 24, 2016

I read with appreciation the special editorial by Susan Schneider Williams, [1] in which she shares personal details about the tragic death of her husband, Robin Williams, in the face of Lewy body disease. The death of such a talented actor and comedian was a terrible loss to the world. I share my deepest condolences.

In her editorial, Mrs. Williams made one comment of particular importance: "...his medication was switched from Mirapex [pramipexole, a dopamine agonist] to Sinemet [carbidopa/levodopa]..." near the end of July, just before his death on August 11th. This raises the possibility that his suicidality may have been a manifestation of dopamine agonist withdrawal syndrome (DAWS). [2] DAWS is a stereotyped drug withdrawal syndrome that can cause a variety of nonmotor symptoms, including severe and medically-refractory anxiety, panic attacks, depression, dysphoria, fatigue, and suicidality. DAWS does not respond to carbidopa/levodopa or other medications and can be very difficult to recognize because the symptoms are not visible and closely mimic those of a primary psychiatric disorder. [2,3]

Mrs. Williams wrote this piece to "...help make a difference in the lives of others." [1] Her advocacy has undoubtedly raised awareness of Lewy body disease, for which there are currently no adequate treatments. I hope her words and actions will also lead to greater recognition of DAWS and other serious, underrecognized, and preventable complications of dopaminergic therapy. [2-4]

1. Williams SS. The terrorist inside my husband's brain. Neurology 2016;87:1308-1311.

2. Rabinak CA, Nirenberg MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 2010;67:58-63.

3. Nirenberg MJ. Dopamine agonist withdrawal syndrome: implications for patient care. Drugs Aging 2013;30:587-592.

4. Weintraub D, Nirenberg MJ. Impulse control and related disorders in Parkinson's disease. Neurodegener Dis 2013;11:63-71.

For disclosures, please contact the editorial office at journal@neurology.org.

Navigate back to article

Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise